Cargando…
The propionic acid and butyric acid in serum but not in feces are increased in patients with diarrhea-predominant irritable bowel syndrome
BACKGROUND: Short-chain fatty acids (SCFAs) alteration have been reported in irritable bowel syndrome (IBS), but the results are conflicting. Our study aims to explore the alteration of SCFAs in patients with diarrhea-predominant IBS (IBS-D) and their potential role in the occurrence and development...
Autores principales: | Tian, Zhenyi, Zhuang, Xiaojun, Luo, Mei, Yin, Wei, Xiong, Lishou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077160/ https://www.ncbi.nlm.nih.gov/pubmed/32178625 http://dx.doi.org/10.1186/s12876-020-01212-3 |
Ejemplares similares
-
Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018) -
Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2020) -
Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis
por: Luo, Mei, et al.
Publicado: (2021) -
Prevalence of lactose intolerance in patients with diarrhea-predominant irritable bowel syndrome: data from a tertiary center in southern China
por: Xiong, Lishou, et al.
Publicado: (2017) -
Butyric acid in irritable bowel syndrome
por: Załęski, Andrzej, et al.
Publicado: (2013)